• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新生儿和心脏手术患儿的患者血液管理:2019 年 NATA 指南。

Patient Blood Management for Neonates and Children Undergoing Cardiac Surgery: 2019 NATA Guidelines.

机构信息

Division of Cardiac Anesthesia, Department of Anesthesia and Pain Medicine, The Hospital for Sick Children, University of Toronto, Toronto, Canada.

Clinic of Anesthesiology and Critical Care Medicine, Kepler University Clinic, Johannes Kepler University Linz, Linz, Austria.

出版信息

J Cardiothorac Vasc Anesth. 2019 Dec;33(12):3249-3263. doi: 10.1053/j.jvca.2019.03.036. Epub 2019 Mar 20.

DOI:10.1053/j.jvca.2019.03.036
PMID:31076306
Abstract

Pediatric cardiac surgery is associated with a substantial risk of bleeding, frequently requiring the administration of allogeneic blood products. Efforts to optimize preoperative hemoglobin, limit blood sampling, improve hemostasis, reduce bleeding, correct coagulopathy, and incorporate blood sparing techniques (including restrictive transfusion practices) are key elements of patient blood management (PBM) programs, and should be applied to the pediatric cardiac surgical population as across other disciplines. Many guidelines for implementation of PBM in adults undergoing cardiac surgery are available, but evidence regarding the implementation of PBM in children is limited to systematic reviews and specific guidelines for the pediatric cardiac population are missing. The objective of the task force from the Network for the Advancement of Patient Blood Management, Haemostasis and Thrombosis (NATA, www.nataonline.com) is to provide evidence-based recommendations regarding anemia management and blood transfusion practices in the perioperative care of neonates and children undergoing cardiac surgery, and to highlight potential areas where additional research is urgently required.

摘要

儿科心脏手术伴随着大量出血的风险,常常需要输注异体血液制品。优化术前血红蛋白水平、限制采血、改善止血、减少出血、纠正凝血障碍以及采用血液保护技术(包括限制性输血策略)是患者血液管理(PBM)计划的关键要素,并且应该应用于儿科心脏手术患者,如同应用于其他学科。有许多关于成人心脏手术患者实施 PBM 的指南,但关于儿童患者 PBM 实施的证据仅限于系统评价,并且缺乏针对儿科心脏患者的具体指南。该工作组的目标是为新生儿和儿童心脏手术患者围手术期贫血管理和输血实践提供基于证据的推荐,并强调需要紧急开展额外研究的潜在领域。

相似文献

1
Patient Blood Management for Neonates and Children Undergoing Cardiac Surgery: 2019 NATA Guidelines.新生儿和心脏手术患儿的患者血液管理:2019 年 NATA 指南。
J Cardiothorac Vasc Anesth. 2019 Dec;33(12):3249-3263. doi: 10.1053/j.jvca.2019.03.036. Epub 2019 Mar 20.
2
Pediatric Patient Blood Management Programs: Not Just Transfusing Little Adults.儿科患者血液管理计划:不仅仅是给小大人输血。
Transfus Med Rev. 2016 Oct;30(4):235-41. doi: 10.1016/j.tmrv.2016.07.004. Epub 2016 Aug 1.
3
Society for the advancement of blood management administrative and clinical standards for patient blood management programs. 4th edition (pediatric version).血液管理促进协会患者血液管理项目的行政和临床标准。第4版(儿科版)。
Paediatr Anaesth. 2019 Mar;29(3):231-236. doi: 10.1111/pan.13574.
4
Current and future trends in coagulation management for congenital heart surgery.先天性心脏病手术凝血管理的当前及未来趋势
J Thorac Cardiovasc Surg. 2017 Jun;153(6):1511-1515. doi: 10.1016/j.jtcvs.2016.11.075. Epub 2017 Feb 16.
5
Patient Blood Management in Pediatric Cardiac Surgery: A Review.小儿心脏外科学中的患者血液管理:综述。
Anesth Analg. 2018 Oct;127(4):1002-1016. doi: 10.1213/ANE.0000000000002504.
6
Comparison of blood-sparing efficacy of ε-aminocaproic acid and tranexamic acid in newborns undergoing cardiac surgery.ε-氨基己酸与氨甲环酸对接受心脏手术新生儿的血液保护效果比较。
Thorac Cardiovasc Surg. 2011 Aug;59(5):276-80. doi: 10.1055/s-0030-1250645. Epub 2011 Mar 21.
7
Perioperative Patient Blood Management to Improve Outcomes.围手术期患者血液管理以改善结局。
Anesth Analg. 2018 Nov;127(5):1211-1220. doi: 10.1213/ANE.0000000000002549.
8
A review of European guidelines for patient blood management with a particular emphasis on antifibrinolytic drug administration for cardiac surgery.一篇关于欧洲患者血液管理指南的综述,特别强调心脏手术中抗纤维蛋白溶解药物的应用。
J Clin Anesth. 2022 Jun;78:110654. doi: 10.1016/j.jclinane.2022.110654. Epub 2022 Jan 19.
9
[Implementation of blood sparing programs in Spain: results of a survey of departments of anesthesiology and resuscitation].[西班牙血液保护计划的实施:麻醉与复苏科室调查结果]
Rev Esp Anestesiol Reanim. 2015 Jun;62 Suppl 1:3-18. doi: 10.1016/S0034-9356(15)30002-5.
10
Epsilon aminocaproic acid reduces blood transfusion and improves the coagulation test after pediatric open-heart surgery: a meta-analysis of 5 clinical trials.ε-氨基己酸可减少小儿心脏直视手术后的输血并改善凝血试验:5项临床试验的荟萃分析
Int J Clin Exp Pathol. 2015 Jul 1;8(7):7978-87. eCollection 2015.

引用本文的文献

1
Pre-bypass ultrafiltration reduces cytokine burden of blood prime in pediatric cardiac surgery.体外循环前超滤可减轻小儿心脏手术中预充液的细胞因子负荷。
Sci Rep. 2025 Aug 25;15(1):31271. doi: 10.1038/s41598-025-15746-7.
2
Patient Blood Management in Pediatric Patients: Current Strategies and Future Perspectives.儿科患者的患者血液管理:当前策略与未来展望
Turk J Haematol. 2025 Aug 29;42(3):170-180. doi: 10.4274/tjh.galenos.2025.2025.0301. Epub 2025 Aug 12.
3
[Explanation and interpretation of blood transfusion provisions for children undergoing cardiac surgery in the national health standard "Guideline for pediatric transfusion"].
[《儿科输血指南》国家卫生标准中儿童心脏手术输血规定的解释与解读]
Zhongguo Dang Dai Er Ke Za Zhi. 2025 Jul 15;27(7):778-785. doi: 10.7499/j.issn.1008-8830.2503114.
4
Red blood cell transfusion management for people undergoing cardiac surgery for congenital heart disease.先天性心脏病心脏手术患者的红细胞输血管理
Cochrane Database Syst Rev. 2025 Mar 19;3(3):CD009752. doi: 10.1002/14651858.CD009752.pub3.
5
Development and validation of a nomogram for predicting perioperative transfusion in children undergoing cardiac surgery with CPB.用于预测接受体外循环心脏手术儿童围手术期输血的列线图的开发与验证。
BMC Anesthesiol. 2025 Jan 31;25(1):49. doi: 10.1186/s12871-025-02917-2.
6
Perioperative considerations in the paediatric patient with congenital and acquired coagulopathy.患有先天性和获得性凝血病的儿科患者围手术期的注意事项。
BJA Open. 2024 Sep 23;12:100310. doi: 10.1016/j.bjao.2024.100310. eCollection 2024 Dec.
7
Effects of Fibrinogen Concentrate Supplementation on Postoperative Bleeding in Infants Undergoing Complex Cardiac Surgery.补充纤维蛋白原浓缩物对接受复杂心脏手术的婴儿术后出血的影响。
Pediatr Cardiol. 2025 Jun;46(5):1381-1389. doi: 10.1007/s00246-024-03559-w. Epub 2024 Jul 9.
8
Prophylactic Transfusion Strategies in Children Supported by Extracorporeal Membrane Oxygenation: The Pediatric Extracorporeal Membrane Oxygenation Anticoagulation CollaborativE Consensus Conference.体外膜肺氧合支持的儿童预防性输血策略:儿科体外膜肺氧合抗凝协作共识会议。
Pediatr Crit Care Med. 2024 Jul 1;25(7 Suppl 1):e25-e34. doi: 10.1097/PCC.0000000000003493. Epub 2024 Jul 3.
9
Long-Term Safety Analysis of a Fibrinogen Concentrate (RiaSTAP/Haemocomplettan P).纤维蛋白原浓缩物(瑞斯托合并帕/海莫科普莱坦 P)的长期安全性分析。
Clin Appl Thromb Hemost. 2024 Jan-Dec;30:10760296241254106. doi: 10.1177/10760296241254106.
10
Transfusion targets and adverse events in pediatric perioperative acute Anemia.小儿围手术期急性贫血的输血目标及不良事件
J Clin Anesth. 2024 Jun;94:111405. doi: 10.1016/j.jclinane.2024.111405. Epub 2024 Feb 2.